Inhibition of Hepatoma Cell Growth in Vitro by Arylating and Non-arylating K Vitamin Analogs
Open Access
- 1 December 1999
- journal article
- Published by Elsevier
- Vol. 274 (49) , 34803-34810
- https://doi.org/10.1074/jbc.274.49.34803
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Activation Mechanism of the MAP Kinase ERK2 by Dual PhosphorylationCell, 1997
- Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine PhosphatasesJournal of Biological Chemistry, 1996
- Association of the protein tyrosine phosphatase PTP1C with the protein tyrosine kinase c-Src in human plateletsFEBS Letters, 1996
- Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activationCell, 1995
- DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled waterAnalytical Biochemistry, 1990
- Redox cycling and sulphydryl arylation; Their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytesChemico-Biological Interactions, 1988
- Reactivity of thiols towards derivatives of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agentsChemico-Biological Interactions, 1987
- Interaction of menadione (2-methyl-1,4-naphthoquinone) with glutathioneChemico-Biological Interactions, 1985
- Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadateBiochemical and Biophysical Research Communications, 1982
- Vitamin K3 (menadione) inhibits the growth of mammalian tumor cells in cultureLife Sciences, 1981